Oshita S, Sada H, Kojima M, Ban T
Naunyn Schmiedebergs Arch Pharmacol. 1980 Oct;314(1):67-82. doi: 10.1007/BF00498433.
Effects of lidocaine and tocainide on transmembrane potentials were studied in isolated guinea-pig papillary muscles, superfused with modified Tyrode's solution containing either 5.4, 2.7, 10.0 or 8.1 mmol/l potassium concentration, [K]0. The last solution applied contained either 1.8 (normal [Ca]0) or 7.2 mmol/l [Ca]0 (high [Ca]0. The concentrations of lidocaine and tocainide used were 18.5, 36.9 and 73.9 mumol/l and 43.7, 87.5 and 174.9 mumol/l in 5.4 mmol/l [K]0 solution and 36.9 and 87.5 mumol/l in the other solutions, respectively. At the driving rate of 1 Hz in 5.4 mmol/l "K]0 solution, both drugs produced dose-dependently a reduction of maximum rate of rise of action potential (Vmax), together with a prolongation of the relative refractory period. Vmax decreased progressively as the driving rate was increased from 1 Hz (for lidocaine) and from 0.25 Hz (for tocainide) to 5 Hz. This action was accentuated dose-dependently. A slow component (time constant tau = 232 ms for lidocaine, 281--303 ms for tocainide) and slower component (tau = 2.1--3.8 s for tocainide) of the recovery (reactivation) of Vmax were observed in premature responses at 0.25 Hz and in the first response after interruption of the basic driving rate at 1 Hz. All these effects were accentuated with rising [K]0 and attenuated in the high [Ca]0 solution. Both drugs abbreviated the action potential duration at 50% (APD50) and 90% (APD90) levels at 5.4, 8.1 and 10.0 mmol/l [K]0 but not at 2.7 mmol/l [K]0 nor a high [Ca]0 at 1 Hz. These [K]0-dependent effects of lidocaine on Vmax were successfully simulated by the model proposed by Hondeghem and Katzung (1977), with a slight change in parameter values. The mode of interaction of lidocaine with sodium channels in the open, closed and rested states was deduced from these results.
在离体豚鼠乳头肌中研究了利多卡因和妥卡尼对跨膜电位的影响,乳头肌用含有5.4、2.7、10.0或8.1mmol/L钾浓度([K]0)的改良台氏液进行 superfused。最后应用的溶液含有1.8(正常[Ca]0)或7.2mmol/L[Ca]0(高[Ca]0)。在5.4mmol/L[K]0溶液中使用的利多卡因和妥卡尼浓度分别为18.5、36.9和73.9μmol/L以及43.7、87.5和174.9μmol/L,在其他溶液中分别为36.9和87.5μmol/L。在5.4mmol/L“K]0溶液中以1Hz的驱动频率,两种药物均剂量依赖性地使动作电位最大上升速率(Vmax)降低,同时相对不应期延长。随着驱动频率从1Hz(利多卡因)和0.25Hz(妥卡尼)增加到5Hz,Vmax逐渐降低。这种作用呈剂量依赖性增强。在0.25Hz的早搏反应以及1Hz基本驱动频率中断后的第一个反应中,观察到Vmax恢复(再激活)的慢成分(利多卡因的时间常数τ = 232ms,妥卡尼的时间常数τ = 281 - 303ms)和更慢成分(妥卡尼的τ = 2.1 - 3.8s)。随着[K]0升高,所有这些效应均增强,而在高[Ca]0溶液中则减弱。在5.4、8.1和10.0mmol/L[K]0时,两种药物均使动作电位持续时间在50%(APD50)和90%(APD90)水平缩短,但在2.7mmol/L[K]0时以及1Hz的高[Ca]0时则不然。利多卡因对Vmax的这些[K]0依赖性效应通过Hondeghem和Katzung(1977)提出的模型成功模拟,参数值略有变化。从这些结果推导了利多卡因与处于开放、关闭和静息状态钠通道的相互作用方式。 (注:“superfused”这个词不太准确,可能是“superfused”,意为“灌流”,这里按此翻译,你可根据实际情况调整。)